Bank of the West’s Bristol-Myers Squibb BMY Stock Holding History

Bank of the West’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3.68M	Buy	51,129 +6,973	+16%	+$526K	0.43%	69
2022 Q3	$3.14M	Buy	44,156 +982	+2%	+$71.2K	0.41%	69
2022 Q2	$3.33M	Buy	43,174 +4,416	+11%	+$336K	0.42%	70
2022 Q1	$2.83M	Sell	38,758 -584	-1%	-$39.2K	0.29%	92
2021 Q4	$2.45M	Sell	39,342 -70,817	-64%	-$4.15M	0.23%	100
2021 Q3	$6.52M	Buy	110,159 +3,863	+4%	+$254K	0.68%	39
2021 Q2	$7.1M	Buy	106,296 +22,489	+27%	+$1.47M	0.72%	37
2021 Q1	$5.29M	Buy	83,807 +4,178	+5%	+$260K	0.6%	49
2020 Q4	$4.94M	Buy	79,629 +7,930	+11%	+$488K	0.58%	50
2020 Q3	$4.32M	Buy	71,699 +16,680	+30%	+$1M	0.58%	47
2020 Q2	$3.23M	Buy	55,019 +2,876	+6%	+$172K	0.44%	62
2020 Q1	$2.91M	Sell	52,143 -361	-0.7%	-$22.1K	0.45%	56
2019 Q4	$3.37M	Buy	52,504 +9,095	+21%	+$521K	0.39%	72
2019 Q3	$2.2M	Buy	43,409 +23,671	+120%	+$1.11M	0.27%	96
2019 Q2	$895K	Sell	19,738 -41	-0.2%	-$1.91K	0.11%	155
2019 Q1	$943K	Buy	19,779 +482	+2%	+$24K	0.11%	150
2018 Q4	$1M	Sell	19,297 -187	-1%	-$10K	0.12%	151
2018 Q3	$1.21M	Sell	19,484 -777	-4%	-$46.1K	0.14%	144
2018 Q2	$1.12M	Sell	20,261 -364	-2%	-$19.7K	0.14%	157
2018 Q1	$1.3M	Buy	20,625 +59	+0.3%	+$3.79K	0.16%	154
2017 Q4	$1.26M	Sell	20,566 -85	-0.4%	-$5.32K	0.16%	147
2017 Q3	$1.32M	Sell	20,651 -2,371	-10%	-$138K	0.17%	143
2017 Q2	$1.28M	Sell	23,022 -1,487	-6%	-$80.9K	0.17%	146
2017 Q1	$1.33M	Sell	24,509 -4,053	-14%	-$222K	0.17%	142
2016 Q4	$1.67M	Sell	28,562 -1,212	-4%	-$66.3K	0.23%	119
2016 Q3	$1.61M	Sell	29,774 -4,272	-13%	-$274K	0.22%	119
2016 Q2	$2.5M	Sell	34,046 -152	-0.4%	-$10.7K	0.36%	80
2016 Q1	$2.19M	Sell	34,198 -790	-2%	-$49.8K	0.3%	100
2015 Q4	$2.41M	Sell	34,988 -12,626	-27%	-$834K	0.33%	90
2015 Q3	$2.82M	Sell	47,614 -1,729	-4%	-$110K	0.45%	71
2015 Q2	$3.28M	Sell	49,343 -1,314	-3%	-$86.6K	0.47%	68
2015 Q1	$3.27M	Sell	50,657 -10,914	-18%	-$683K	0.46%	72
2014 Q4	$3.63M	Buy	61,571 +8,994	+17%	+$507K	0.53%	64
2014 Q3	$2.69M	Sell	52,577 -18,241	-26%	-$911K	0.46%	76
2014 Q2	$3.44M	Sell	70,818 -5,399	-7%	-$266K	0.54%	71
2014 Q1	$3.96M	Buy	76,217 +45	+0.1%	+$2.39K	0.65%	50
2013 Q4	$4.05M	Sell	76,172 -6,709	-8%	-$342K	0.64%	49
2013 Q3	$3.84M	Buy	82,881 +3,748	+5%	+$165K	0.7%	50
2013 Q2	$3.54M	Buy	+79,133	New	+$3.44M	0.66%	49

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Bank of the West's BMY Position: Q4 2022 in Review

Bank of the West increased its Bristol-Myers Squibb (BMY) stake by 16% in Q4 2022, buying an estimated $526K and bringing the position to 51,129 shares worth $3.68M. The position accounts for 0.43% of the portfolio, ranked #69.

Bank of the West first reported a position in BMY in Q2 2013 and has held it in 39 quarters since. The position peaked at $7.1M in Q2 2021. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Bank of the West held 51,129 shares of Bristol-Myers Squibb worth $3.68M as of Q4 2022.
Bank of the West bought 6,973 Bristol-Myers Squibb shares in Q4 2022, an estimated $526K.
Bristol-Myers Squibb made up 0.43% of Bank of the West's portfolio in Q4 2022, its #69 holding.
Bank of the West first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 39 quarters since.
Bank of the West's Bristol-Myers Squibb position peaked at $7.1M in Q2 2021.
2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Bank of the West's 13F filing for Q4 2022, filed 1 Feb 2023.